from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3584/lpqE

LFCtreatmentdescriptionclass of inhibitor

0.569

Amikacinug/mL Amikacintranslation

1.389

Cap5-10ug/mL Capreomycintranslation

0.877

Rox10-50 ug/mL Roxithromycintranslation

0.699

SM2-5 ug/mL Streptomycintranslation

-0.348

Tet5-10 ug/mL Tetracyclinetranslation

-0.997

Rif0.2-5ug/mL Rifampicintranscription

-1.218

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.773

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.092

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.607

CPZ10-50 ug/mL Chlorpromazinerespiration

0.340

Clofazimine10-13 ug/mL Clofaziminerespiration

0.417

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.874

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.819

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.345

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.722

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.550

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.974

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.260

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.058

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.157

KCN5-20 ug/mL Potassium cyaniderespiration

0.226

NaN30.2-2 mM Sodium aziderespiration

1.130

Nigericin50 uM Nigericinrespiration

-2.029

TRC10-150 ug/mL Triclosanrespiration

-1.396

TRZ10-25 ug/mL Thioridazinerespiration

-0.902

Valinomycin0.5-10 uM Valinomycinrespiration

1.270

ZnSO42 mM ZnSO4respiration

0.065

menadione6-10 ug/mL Menadionerespiration

0.649

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.511

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.630

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.726

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.320

NRP_1Non-replicating persistence stage 1dosRassociated

0.421

Amp0.2mg/mL AmpicillincellWall

0.112

Cephalexin20-100 ug/mL CephalexincellWall

0.824

Cerulenin0.32-5 ug/mL CerulenincellWall

0.076

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.611

EMB10-20 ug/mL EthambutolcellWall

1.006

Eta12-40 ug/mL EthionamidecellWall

1.012

INH0.2-0.4 ug/mL IsoniazidcellWall

0.629

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.501

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.414

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.719

BZA0.12 mg/mL BenzamidearomaticAmides

-0.380

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.407

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.410

H2O24 mM hydrogen peroxideDNAdamaging

0.889

Levo10 ug/mL LevofloxacinDNAdamaging

0.537

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.626

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.972

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.575

UVUV-irradiationDNAdamaging

-0.854

ARP41-4 ug/mL Antitubercular compound ARP4?

0.640

Antimycin12.5-50 ug/mL Antimycin A?

0.231

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.317

PA_110-50 ug/mL Antitubercular compound PA-1?

0.325

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.475

PA8240.2-2 ug/mL PA-824?

-1.161

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.184

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.026

Verapamil50 uM Verapamil?

0.419

mercaptoethanol2 mM 2-Mercaptoethanol?

0.292

methoxatin10-20 ug/mL Methoxatin?